These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 27189160)

  • 1. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
    Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
    Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
    BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
    Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.
    Wang J; Ni J; Beretov J; Thompson J; Graham P; Li Y
    Crit Rev Oncol Hematol; 2020 Jan; 145():102860. PubMed ID: 31874447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Analysis of Tissue-Derived and Biofluid Extracellular Vesicle miRNAs Associated with Prostate Cancer.
    Larson J; Ozen MO; Kohli M; Akin D; Demirci U
    Adv Biol (Weinh); 2023 Jul; 7(7):e2200327. PubMed ID: 37300338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.
    Paziewska A; Mikula M; Dabrowska M; Kulecka M; Goryca K; Antoniewicz A; Dobruch J; Borowka A; Rutkowski P; Ostrowski J
    Prostate; 2018 Feb; 78(3):178-185. PubMed ID: 29226351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
    Mercadal M; Herrero C; López-Rodrigo O; Castells M; de la Fuente A; Vigués F; Bassas L; Larriba S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.
    Bertoli G; Cava C; Castiglioni I
    Int J Mol Sci; 2016 Mar; 17(3):421. PubMed ID: 27011184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs Role in Prostate Cancer.
    Balacescu O; Dumitrescu RG; Marian C
    Methods Mol Biol; 2018; 1856():103-117. PubMed ID: 30178248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity Captured Urinary Extracellular Vesicles Provide mRNA and miRNA Biomarkers for Improved Accuracy of Prostate Cancer Detection: A Pilot Study.
    Davey M; Benzina S; Savoie M; Breault G; Ghosh A; Ouellette RJ
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
    Sharma N; Baruah MM
    Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
    Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA biomarkers in body fluids of prostate cancer patients.
    Kuner R; Brase JC; Sültmann H; Wuttig D
    Methods; 2013 Jan; 59(1):132-7. PubMed ID: 22652624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
    Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy.
    Yoshioka Y; Katsuda T; Ochiya T
    Jpn J Clin Oncol; 2018 Oct; 48(10):869-876. PubMed ID: 30169666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs: macro-utility as markers of prostate cancer?
    Selth LA; Tilley WD; Butler LM
    Endocr Relat Cancer; 2012 Aug; 19(4):R99-R113. PubMed ID: 22492480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence and potential in vivo functions for biofluid miRNAs: From expression profiling to functional testing: Potential roles of extracellular miRNAs as indicators of physiological change and as agents of intercellular information exchange.
    Iftikhar H; Carney GE
    Bioessays; 2016 Apr; 38(4):367-78. PubMed ID: 26934338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.